Cargando…
Oxylipins as Biomarkers for Aromatase Inhibitor-Induced Arthralgia (AIA) in Breast Cancer Patients
Aromatase inhibitor-induced arthralgia (AIA) presents a major problem for patients with breast cancer but is poorly understood. This prospective study explored the inflammatory metabolomic changes in the development of AIA. This single-arm, prospective clinical trial enrolled 28 postmenopausal women...
Autores principales: | Martinez, Jessica A., Wertheim, Betsy C., Roe, Denise J., Taljanovic, Mihra S., Chow, H-H. Sherry, Chew, Wade, Ehsani, Sima, Jiralerspong, Sao, Segar, Jennifer, Chalasani, Pavani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052117/ https://www.ncbi.nlm.nih.gov/pubmed/36984892 http://dx.doi.org/10.3390/metabo13030452 |
Ejemplares similares
-
Feasibility Trial to Evaluate Tendon Stiffness Obtained from Shear Wave Elastography Imaging as a Biomarker of Aromatase Inhibitor-Induced Arthralgias
por: Martinez, Jessica A., et al.
Publicado: (2022) -
Shear wave elastography detects novel imaging biomarkers of aromatase inhibitor–induced joint pain: a pilot study
por: Martinez, Jessica A., et al.
Publicado: (2021) -
Management of aromatase inhibitor–induced arthralgia
por: Younus, J., et al.
Publicado: (2010) -
Management of arthralgias associated with aromatase inhibitor therapy
por: Thorne, C.
Publicado: (2007) -
Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors
por: Romero, Sally A.D., et al.
Publicado: (2019)